Mental disorders in pulmonary hypertension
https://doi.org/10.30629/2618-6667-2019-81-69-81
Abstract
The aim of work: to present the analysis of modern scientific publications on the issue of mental disorders and constitutional-personality characteristics of patients with pulmonary hypertension.
Material and methods: according to the key words «pulmonary hypertension», «pulmonary arterial hypertension» publications over the past two decades were selected and analyzed in the scientific bases PubMed, MEDLINE and others resource.
Results: to date, it is known that pulmonary hypertension is a severe pathological condition which is characterized by a progressive increase of pulmonary vascular resistance and leading to life-threatening complications. Pulmonary hypertension is a multidisciplinary problem. The steady increase in the severity of the main symptoms results in decreased physical activity, quality of life and socio-psychological disorders manifestation. This review carries out the literature data about prevalence and spectrum of mental disorders in dif ferent groups of pulmonar y hyper tension patients. In addition, there were analyzed researches aimed to study constitutional-personality characteristics, coping styles and forming certain types of internal picture of disease.
Conclusion: the general prevalence of anxious and depressive disorders are presented in the literature in the most developed form, however, the issues of the psychopathological structure of disorders, the constitutional-personality predisposition, the formation of the internal picture of the disease in pulmonary hypertension are not covered adequately.
About the Authors
M. A. SamushiyaRussian Federation
Marina A. Samushiya, Dr. of Sci. (Med.), professor
Yu. I. Rozhkova
Russian Federation
Yulia I. Rozhkova
References
1. Simonneau G., Robbins I.M., Beghetti M., Channick R.N., Delcroix M., Denton C.P., Elliott C.G., Gaine S.P., Gladwin M.T., Jing Z., Krowka M.J., Langleben D., Nakanishi N., Souza R. Updated clinical classification of pulmonary hypertension. Journal of the American College of Cardiology. 2009;54:43–54. https://DOI:10.1016/j.jacc.2009.04.012
2. Galiè N., Humbert M., Vachiery J., Gibbs S., Lang I., Torbicki A., Simonneau G., Peacock A., Noordegraaf A., Beghetti A., Ghofrani A., Gomez Sanchez M., Hansmann G., Klepetko W., Lancellotti P., Matucci M., McDonagh T., Pierard L., Trindade P., Zompatori M., Hoeper M. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur. Heart J. 2016;37(1):67–119. https://DOI:10.1093/eurheartj/ehv317
3. Galiè N., Manes A., Negro L., Palazzini M., Bacchi-Reggiani M.L., Branzi A. A meta-analysis of randomized controlled trials in pulmonary arterial hypertension. Eur. Heart J. 2009;30(4):394–403. https://DOI:10.1093/eurheartj/ehp022
4. Barst R.J. Pulmonary hypertension: past, present and future. Annals of Thoracic Medicine. 2008;3(1):1–4. https://DOI:10.4103/1817-1737.37832
5. Shafazand S., Goldstein M.K., Doyle R.L., Hlatky M.A., Gould M.K. Health-related quality of life in patients with pulmonary arterial hypertension. Chest. 2004;126(5):1452–1459. https://DOI:10.1378/chest.126.5.1452
6. Taichman D.B., Shin J., Hud L., Archer-Chicko C., Kaplan S., Sager J.S., Gallop R., Christie J., Hansen-Flaschen J., Palevsky H. Health-related quality of life in patients with pulmonary arterial hypertension. Respiratory Research. 2005; 6:92–102. https://DOI:10.1186/1465-9921-6-92
7. White J., Hopkins R.O., Glissmeyer E.W., Kitterman N., Elliott C.G. Cognitive, emotional, and quality of life outcomes in patients with pulmonary arterial hypertension. Respiratory Research.2006;7:55. https://DOI:10.1186/1465-9921-7-55
8. Looper K.J., Pierre A., Dunkley D.M., Sigal J.J., Langleben D. Depressive symptoms in relation to physical functioning in pulmonary hypertension. J. Psychosomat. Res. 2009;66(3):221–225. https://DOI:10.1016/j.jpsychores.2008.09.014
9. Löwe B., Gräfe K., Ufer C., Kroenke K., Grünig E., Herzog W., Borst M.M. Anxiety and depression in patients with pulmonary hypertension. Psychosomatic Medicine. 2004;66(6):831–836. https://DOI:10.1097/01.psy.0000145593.37594.39
10. Somaini G., Hasler E.D., Saxer S., Huber L.C., Lichtblau M., Speich R., Bloch K.E., Ulrich S. Prevalence of Anxiety and Depression in Pulmonary Hypertension and Changes during Therapy. Respiration. 2016;91(5):359–366. https://DOI:10.1159/000445805
11. Larisch A., Neeb C., Zwaan M. de, Pabst C., Tiede H., Ghofrani A., Olsson K., Hoeper M., Kruse J. Psychische Belastung und Psychosomatischer Behandlungswunsch von Patienten mit Pulmonaler Hypertonie. Psychotherap. Psychosomat. Med. Psychologie. 2014;64(9–10):384–389. https://DOI:10.1055/s-0034-1377013
12. Harzheim D., Klose H., Pinado F.P., Ehlken N., Nagel C., Fischer C., Ghofrani A., Rosenkranz S., Seyfarth H., Halank M., Mayer E., Grünig E., Guth S. Anxiety and depression disorders in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Respiratory Research.2013;14:104. https://DOI:10.1186/1465-9921-14-104
13. Halimi L., Marin G., Molinari N., Gamez A.-S., Boissin C., Suehs Carey М., Vachier I., Bourdin A. Impact of psychological factors on the health-related quality of life of patients treated for pulmonary arterial hypertension. J. Psychosomat. Res. 2018;105:45–51. https://DOI:10.1016/j.jpsychores.2017.12.003
14. Tartavoulle T.M. A predictive model of the effects of depression, anxiety, stress, 6-minute-walk distance, and social support on health-related quality of life in an adult pulmonary hypertension population. Clinical Nurse Specialist. 2015;29(1):22–28. https://DOI:10.1097/NUR.0000000000000099
15. Yorke J., Deaton C., Campbell M., McGowen L., Sephton P., Kiely D.G., Armstrong I. Symptom severity and its effect on health-related quality of life over time in patients with pulmonary hypertension: a multisite longitudinal cohort study. BMJ Open Resp. Res. 2018;5(1):e000263. https://DOI:10.1136/bmjresp-2017-000263
16. McCollister D.H., Beutz M., McLaughlin V., Rumsfeld J., Ma-soudi F.A., Tripputi M., Yaeger T., Weintraub P., Badesch D.B. Depressive Symptoms in Pulmonary Arterial Hypertension: Prevalence and Association With Functional Status. Psycho-somatics. 2010;51(4):339–339. https://DOI:10.1016/S0033-3182(10)70706-4
17. Vanhoof J.M.M., Delcroix M., Vandevelde E., Denhaerynck K., Wuyts W., Belge C., Dobbels F. Emotional symptoms and quality of life in patients with pulmonary arterial hypertension. J. Heart Lung Transplantation. 2014;33(8):800–808. https://DOI:10.1016/j.healun.2014.04.003
18. Von Visger T.T., Kuntz K.K., Phillips G.S., Yildiz V.O., Sood N. Quality of life and psychological symptoms in patients with pulmonary hypertension. Heart & Lung. 2018;47(2):115–121. https://DOI:10.1016/j.hrtlng.2017.12.004
19. Humbert M., Sitbon O., Chaouat A., Bertocchi M., Habib G., Gressin V., Yaici A., Weitzenblum E., Cordier J., Chabot F., Dromer C., Pison C., Reynaud-Gaubert M., Haloun A., Laurent M., Hachulla E., Simonneau G. Pulmonary arterial hypertension in France: Results from a national registry. Am. J. Resp. Crit Care Med. 2006;173(9):1023–1030. https://DOI:10.1164/rccm.200510-1668OC
20. Mukerjee D., St George D., Coleiro B., Knight C., Denton C.P., Davar J., Black C.M., Coghlan J.G. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann. Rheumat. Dis.2003;62(11):1088–1093. https://DOI:10.1136/ard.62.11.1088
21. MacGregor A.J. Pulmonary hypertension in systemic sclerosis: Risk factors for progression and consequences for survival. Rheumatology. 2001;40(4):453–459. https://DOI:10.1093/rheumatology/40.4.453
22. Stupi A.M., Steen V.D., Owens G.R., Barnes E.L., Rodnan G.P., Medsger T.A. Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. Arthritis and Rheumatism.1986;29(4):515–524. https://DOI:10.1002/art.1780290409
23. Koh E. Pulmonary hypertension in systemic sclerosis: An analysis of 17 patients. Rheumatology. 1996;35(10):989–993. https://DOI:10.1093/rheumatology/35.10.989
24. Aronov P.V., Starovojtova M.N., Kovalevskaya O.B., Seravina O.F., Vel’tishchev D.Yu. Stress i depressiya u bol’nyh sistemnoj sklerodermiej (obzor zarubezhnoj literatury). Psihicheskie rasstrojstva v obshchej medicine. 2009;4:17–19. (In Russ.).
25. Mozzetta A., Antinone V., Alfani S., Neri P., Foglio Bonda P.G., Pasquini P., Puddu P., Picardi A. Mental health in patients with systemic sclerosis: a controlled investigation. J. Eur. Acad. Dermatol. Venereol. 2008;22(3):336–340. https://DOI:10.1111 /j.1468-3083.2007.02426.x
26. Thombs B.D., Hudson M., Taillefer S.S., Baron M. Prevalence and clinical correlates of symptoms of depression in patients with systemic sclerosis. Arthritis and Rheumatism. 2008;59(4):504–509. https://DOI:10.1002/art.23524
27. Vanhoof J.M.M., Delcroix M., Vandevelde E., Denhaerynck K., Wuyts W., Belge C., Dobbels F. Emotional symptoms and quality of life in patients with pulmonary arterial hypertension. J. Heart Lung Transplantation. 2014;33(8):800–808. https://DOI:10.1016/j.healun.2014.04.003
28. Von Visger T.T., Kuntz K.K., Phillips G.S., Yildiz V.O., Sood N. Quality of life and psychological symptoms in patients with pulmonary hypertension. Heart & Lung. 2018;47(2):115–121. https://DOI:10.1016/j.hrtlng.2017.12.004
29. Humbert M., Sitbon O., Chaouat A., Bertocchi M., Habib G., Gressin V., Yaici A., Weitzenblum E., Cordier J., Chabot F., Dromer C., Pison C., Reynaud-Gaubert M., Haloun A., Laurent M., Hachulla E., Simonneau G. Pulmonary arterial hypertension in France: Results from a national registry. Am. J. Resp. Crit. Care Med. 2006;173(9):1023–1030. https://DOI:10.1164/rccm.200510-1668OC
30. Sulejmanova G.P., Ramkkhelavon M.B. Psihosomaticheskie sootnosheniya pri sistemnoj sklerodermii. Fundamental’nye issledovaniya. 2013;(7–2):407–411. (In Russ.).
31. Angelopoulos N.V., Drosos A.A., Moutsopoulos H.M. Psychiatric symptoms associated with scleroderma. Psychotherapy and psychosomatics. 2001;70(3):145–150. https://DOI:10.1159/000056240
32. Benrud-Larson L.M., Heinberg L.J., Boling C., Reed J., White B., Wigley F.M., Haythornthwaite J.A. Body image dissatisfaction among women with scleroderma: Extent and relationship to psychosocial function. Health Psychology. 2003;22(2):130–139. https://DOI:10.1037/0278-6133.22.2.130
33. Thombs B.D., Taillefer S.S., Hudson M., Baron M. Depression in patients with systemic sclerosis: a systematic review of the evidence. Arthritis and Rheumatism. 2007;57(6):1089–1097. https://DOI:10.1002/art.22910
34. Roca R.P., Wigley F.M., White B. Depressive symptoms associated with scleroderma. Arthritis & Rheumatism. 1996;39(6):1035–1040. https://DOI:10.1002/art.1780390623
35. Silva A.M., Vaz C., Areias M.E.G., Vieira D., Proença C., Viana V., Moura C., Areias J.C. Quality of life of patients with congenital heart diseases. Cardiology in the Young. 2011;21(6):670–676. https://DOI:10.1017/S1047951111 0 0 0 57 6
36. Müller J., Hess J., Hager A. Minor symptoms of depression in patients with congenital heart disease have a larger impact on quality of life than limited exercise capacity. Int. J. Cardiol.2012;154(3):265–269. https://DOI:10.1016/j.ijcard.2010.09.029
37. Amedro P., Basquin A., Gressin V., Clerson P., Jais X., Thambo J., Guerin P., Cohen S., Bonnet D. Health-related quality of life of patients with pulmonary arterial hypertension associated with CHD: the multicentre cross-sectional ACHILLE study. Cardiology in the Young. 2016;26(7):1250–1259. https://DOI:10.1017/S1047951116000056
38. Alyohin A.N., Andreeva Е.V., Goncharova N.S., Moiseeva O.M., Trifonova Е.A. Kachestvo zhizni i otnoshenie k bolezni pacientov s tyazhelymi formami hronicheskoj serdechnoj nedostatochnosti (na primere legochnoj arterial’noj gipertenzii i sindroma Ejzenmengera). V kn.: Budushchee klinicheskoj psihologii 2012. Materialy VI Vserossijskoj nauchno-prakticheskoj zaochnoj konferencii. Pod red. Levchenko Е.V., Demenevoj A.Е. Perm’: PGNIU; 2012:24–38. (In Russ.).
39. Horner T., Liberthson R., Jellinek M.S. Psychosocial profile of adults with complex congenital heart disease. Mayo Clinic Proceedings. 2000;75(1):31–36. https://DOI:10.4065/75.1.31
40. Westhoff-Bleck M., Briest J., Fraccarollo D., Hilfiker-Klein-er D., Winter L., Maske U., Busch M.A., Bleich S., Bauersachs J., Kahl K.G. Mental disorders in adults with congenital heart dis-ease: Unmet needs and impact on quality of life. J. Affect. Dis.2016;204:180–186. https://DOI:10.1016/j.jad.2016.06.047
41. Bang J.S., Jo S., Kim G.B., Kwon B.S., Bae E.J., Noh C.I., Choi J.Y. The mental health and quality of life of adult patients with congenital heart disease. Int. J. Cardiol. 2013;170(1):49–53. https://DOI:10.1016/j.ijcard.2013.10.003
42. Kovacs A.H., Saidi A.S., Kuhl E.A., Sears S.F., Silversides C., Harrison J.L., Ong L., Colman J., Oechslin E., Nolan R.P. Depression and anxiety in adult congenital heart disease predictors and prevalence. Int. J. Cardiol. 2009;137(2):158–164. https://DOI:10.1016/j.ijcard.2008.06.042
43. Wang Q., Hay M., Clarke D., Menahem S. The prevalence and predictors of anxiety and depression in adolescents with heart disease. J. Pediatr. 2012;161(5):943–946. https://DOI:10.1016/j.jpeds.2012.04.010
44. Bromberg J.I., Beasley P.J., D’Angelo E.J., Landzberg M., DeMaso D.R. Depression and anxiety in adults with congenital heart disease: a pilot study. Heart & Lung. 2003;32:105–110. https://DOI:10.1067/mhl.2003.26
45. O’Donovan C.E., Painter L., Lowe B., Robinson H., Broadbent E. The impact of illness perceptions and disease severity on quality of life in congenital heart disease. Cardiology in the Young.2016;26(1):100–109. https://DOI:10.1017/S1047951114002728
46. Awaad M.I., Darahim K.E. Depression and anxiety in adolescents with congenital heart disease. Middle East Current Psychiatry 2015;22(1):2–8. https://DOI.org/10.1097/01.XME.0000457325.90630.4f
47. Aguirre-Camacho A., Moreno-Jiménez B. Depression and Anxiety in Patients With Pulmonary Hypertension: The Role of Life Satisfaction and Optimism. Psychosomatics. 2018. https://DOI:10.1016/j.psym.2018.04.002
48. Pfeuffer E., Krannich H., Halank M., Wilkens H., Kolb P., Jany B., Held M. Anxiety, Depression, and Health-Related QOL in Patients Diagnosed with PAH or CTEPH. Lung. 2017;195(6):759–768. https://DOI:10.1007/s00408-017-0052-z
49. Funabashi S., Kataoka M., Inami T., Kikuchi T., Yanagisawa R., Ishiguro C., Okamoto S., Yoshino H., Watanabe K., Satoh T. Depressive Status in Patients With Chronic Thromboembolic Pulmonary Hypertension. Circulation J. 2017;81:1051–1053. https://DOI:10.1253/circj.CJ-17-0197
50. Rohlin L.L. «Soznanie bolezni» i ego znachenie v klinicheskoj praktike. Klinicheskaya medicina. 1957; 35(9):11–21. (In Russ.).
51. Pieringer W. Psychosomatische und somatopsychische Aspekte der progressiv chronischen Polyarthritis. Wien Klin. Wochenschr. 1978;(94):17–20.
52. Smulevich A.B. Rasstrojstva lichnosti. Traektoriya v prostranstve psihicheskoj i somaticheskoj patologii. M.: Medicinskoe informacionnoe agentstvo; 2012. (In Russ.).
53. Wryobeck J.M., Lippo G., McLaughlin V., Riba M., Rubenfire M. Psychosocial aspects of pulmonary hypertension: a review. Psychosomatics. 2007;48(6):467–475. https://DOI:10.1176/appi.psy.48.6.467
54. Kingman M., Hinzmann B., Sweet O., Vachiéry J. Living with pulmonary hypertension: unique insights from an international ethnographic study. BMJ Open. 2014;4(5):e004735. https://DOI:10.1136/bmjopen-2013-004735
55. Gihl A.F. Health-related quality of life in pulmonary arterial hypertension. Advances in Pulmonary Hypertension.2010;8(4):215–222, 55.
56. Guillevin L., Armstrong I., Aldrighetti R., Howard L.S., Ryftenius H., Fischer A., Lombardi S., Studer S., Ferrari P. Understanding the impact of pulmonary arterial hypertension on patients’ and carers’ lives. Eur. Resp. Rev. 2013;22(130):535–542. https://DOI:10.1183/09059180.00005713
57. Flattery M.P., Pinson J.M., Savage L., Salyer J. Living with pulmonary artery hypertension: patients’ experiences. Heart & Lung. 2005;34(2):99–107. https://DOI:10.1016/j.hrtlng.2004.06.010
58. Luriya R.A. Vnutrennyaya kartina bolezni i yatrogennye zabolevaniya. 4-e izd. M.: Medicina; 1977. (In Russ.).
59. Vasserman L.I., Iovlev B.V., Karpova E.B., Vuks A.Ya. Psihologicheskaya diagnostika otnosheniya k bolezni: posobie dlya vrachej. SPb.: NIPNI im. V.M. Bekhtereva; 2005. (In Russ.).
60. Alyohin A.N., Chumakova I.O., Andreeva Е.V., Trifonova Е.A. Klinicheskie faktory psihicheskoj adaptacii pacientov s serdechno–sosudistoj patologiej (na primere legochnoj arterial’noj gipertenzii i fibrillyacii predserdij). Vestnik YUzhno-Ural’skogo gosudarstvennogo universiteta. Seriya: Psihologiya.2012;6(265):66–72. (In Russ.).
61. Andreeva Е.V. Psihologicheskaya adaptaciya k bolezni v klinicheskoj dinamike legochnoj arterial’noj gipertenzii u zhenshchin. Izvestiya RGPU im. A.I. Gercena. 2012:159–164. (In Russ.).
62. Martens E.J., Mols F., Burg M.M., Denollet J. Type D personality predicts clinical events after myocardial infarction, above and beyond disease severity and depression. J. Clin. Psychiatry. 2010;71(6):778–783. https://DOI:10.1136/10.4088/JCP.08m04765blu
63. Schoormans D., Mulder B.J., van Melle J.P., Pieper E.G., van Dijk A.P., Sieswerda G.T., Hulsbergen-Zwarts M.S., Plokker T.H., Brunninkhuis L.G., Vliegen H.W., Sprangers M.A. Patients with a congenital heart defect and type D personality feel functionally more impaired, report a poorer health status and quality of life, but use less healthcare. Eur. J. Cardiovasc. Nurs. 2012;11(3):349–355. DOI:10.1177/1474515112437828
64. Gorbatova M.L. Patoharakterologicheskie osobennosti invalidov molodogo vozrasta s vrozhdennym porokom serdca. Psihologicheskie issledovaniya v praktike vrachebno-trudovoj ekspertizy i social’no-trudovoj reabilitacii: Sbornik nauchnyh trudov. M.; 1989. (In Russ.).
65. Drozdova I.V., Lysunec Е.M. Psihologicheskie osobennosti bol’nyh s operirovannymi vrozhdennymi anomaliyami serdca. Mezhdunarodnyj medicinskij zhurnal. 2010;16(3):6–11. (In Russ.).
66. Drozdova I.V., Lysunec Е.M., Moroz S.M. Lichnostnye osobennosti bol’nyh s operirovannymi vrozhdennymi porokami serdca. Mezhdunarodnyj medicinskij zhurnal. 2010;16(4):8–10. (In Russ.).
Review
For citations:
Samushiya M.A., Rozhkova Yu.I. Mental disorders in pulmonary hypertension. Psychiatry (Moscow) (Psikhiatriya). 2019;(81):69-81. (In Russ.) https://doi.org/10.30629/2618-6667-2019-81-69-81